NCT05736575 (BDNF) is a clinical trial of BDNF analysis (Elisa KIT) in Chronic Pain, sponsored by Universidad Autonoma de Madrid.

Who is sponsoring NCT05736575?

NCT05736575 is sponsored by Universidad Autonoma de Madrid.

What drugs are being tested in NCT05736575?

Interventions in NCT05736575: BDNF analysis (Elisa KIT).

What condition does NCT05736575 study?

NCT05736575 studies Chronic Pain.

Is NCT05736575 still recruiting?

NCT05736575 is currently status unknown. Last updated 30 November 2023.

Last reviewed 2023-11-30 · How we verify

NCT05736575: BDNF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients

Status unknown Last updated 30 November 2023

What this trial tests

trial testing BDNF analysis (Elisa KIT) in Chronic Pain in 66 participants. Status unknown.

Timeline

15 May 2023

Primary endpoint
28 February 2024

30 December 2024

Quick facts

Lead sponsor	Universidad Autonoma de Madrid
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	66
Start date	15 May 2023
Primary completion	28 February 2024
Estimated completion	30 December 2024
Sites	1 location across Spain

Drugs / interventions tested

BDNF analysis (Elisa KIT)

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Universidad Autonoma de Madrid — full company profile →

Who can join

Adults 18 to 65, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A case-control study will be conducted to analyze the differences in BDNF levels between patients with chronic pain and asymptomatic people.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Universidad Autonoma de Madrid trials

Trials by the same sponsor.

NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
NCT06726447 — Artificial Intelligence Satisfaction in Professionals and Patients · NA · recruiting
NCT06601478 — Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinica · NA · recruiting
NCT05623579 — Education on BDNF on Pain Levels · NA · unknown
NCT05736172 — 3h of PNE on BDNF and Pain Levels · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05736575 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Madrid
Last refreshed: 30 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05736575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing